News

A group of students smile together while gathering around a table decorated in a red cloth with red and blue balloons in the background.

First Doctor of Physical Therapy Program students begin studies

The Class of 2028 met for the first time and kicked off its three-year journey in the long-awaited program.

Repurposed multiple sclerosis drug could help bones heal faster

Repurposed multiple sclerosis drug could help bones heal faster

A doctor applies sensors to the arm of a person sitting on a bed in a sleep lab while another person monitors the sensor output on a small digital device on the wall.

Putting sleep at the center of health care

An image if two liquid chemotherapy drugs in small bottles next to a needle laying on top of a plastic collection bag

Repackaged cancer drug boosts delivery to tumors, improves combination therapies

Uniquely U of A Health Sciences

The University of Arizona College of Medicine – Tucson celebrates its 55th anniversary this month.

Multigenerational Faculty Members Take Long View

Expert Available for Comment on Great American Smokeout

(From left) John-Paul Roczniak, president and CEO of the University of Arizona Foundation, Fayez K. Ghishan, MD, director of the Steele Children's Research Center, Marianne Cracchiolo Mago, president and CEO of the Steele Foundation, and Robert C. Robbins, MD, University of Arizona President, announced the Steele Foundation’s $10 million gift to the University of Arizona on Nov. 2 at a Wonder Unites Us luncheon in Scottsdale, Arizona.

Pediatric Autoimmune Research Bolstered by $10M Gift

(From left) John-Paul Roczniak, president and CEO of the University of Arizona Foundation, Fayez K. Ghishan, MD, director of the Steele Children's Research Center, Marianne Cracchiolo Mago, president and CEO of the Steele Foundation, and Robert C. Robbins, MD, University of Arizona President, announced the Steele Foundation’s $10 million gift to the University of Arizona on Nov. 2 at a Wonder Unites Us luncheon in Scottsdale, Arizona.

Pediatric Autoimmune Research Bolstered by $10M Gift

The Center for Advanced Molecular and Immunological Therapies, or CAMI, will support research to catalyze the next generation of precision health care treatments.

State Invests $150M For New UArizona Health Sciences Center

The Center for Advanced Molecular and Immunological Therapies, or CAMI, will support research to catalyze the next generation of precision health care treatments.

State Invests $150M For New UArizona Health Sciences Center

CAMI will support research to catalyze the next generation of precision health care treatments and serve as a hub to advance knowledge of the immunology of cancers, autoimmune conditions and infectious diseases.

New UArizona Health Sciences Center Receives $150M State Investment Plus Philanthropic Support

CAMI will support research to catalyze the next generation of precision health care treatments and serve as a hub to advance knowledge of the immunology of cancers, autoimmune conditions and infectious diseases.

New UArizona Health Sciences Center Receives $150M State Investment Plus Philanthropic Support

A new study found that anti-hyperglycemic medications used to treat Type 2 diabetes resulted in an increased risk of multiple sclerosis for people older than 45, particularly among women.

New Study Identifies Connection Between Diabetes Medications, Multiple Sclerosis

The results of a recent study suggest that blue-wavelength light therapy may be useful for improving sleep and reducing PTSD symptoms while increasing the efficacy of treatments in individuals with clinically significant levels of PTSD.

Morning Blue Light Treatment Improves Sleep in Patients With PTSD

A new study found that anti-hyperglycemic medications used to treat Type 2 diabetes resulted in an increased risk of multiple sclerosis for people older than 45, particularly among women.

New Study Identifies Connection Between Diabetes Medications, Multiple Sclerosis

The results of a recent study suggest that blue-wavelength light therapy may be useful for improving sleep and reducing PTSD symptoms while increasing the efficacy of treatments in individuals with clinically significant levels of PTSD.

Morning Blue Light Treatment Improves Sleep in Patients With PTSD